Susan Celia Hellerstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perimenopause | 1 | 2023 | 142 | 0.780 |
Why?
|
| Obstetrics | 2 | 2016 | 668 | 0.600 |
Why?
|
| Cesarean Section | 3 | 2016 | 1399 | 0.560 |
Why?
|
| Urban Health Services | 1 | 2014 | 176 | 0.430 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 418 | 0.360 |
Why?
|
| Feeding Behavior | 1 | 2023 | 3183 | 0.360 |
Why?
|
| Rural Health Services | 1 | 2014 | 384 | 0.360 |
Why?
|
| Prenatal Care | 2 | 2016 | 1141 | 0.310 |
Why?
|
| Cooking | 1 | 2023 | 309 | 0.180 |
Why?
|
| China | 4 | 2016 | 2374 | 0.170 |
Why?
|
| Patient Preference | 2 | 2016 | 927 | 0.150 |
Why?
|
| Fruit | 1 | 2023 | 1158 | 0.140 |
Why?
|
| Vegetables | 1 | 2023 | 1192 | 0.140 |
Why?
|
| Progesterone | 2 | 2003 | 742 | 0.080 |
Why?
|
| Pregnancy | 8 | 2016 | 29893 | 0.080 |
Why?
|
| Diet | 1 | 2023 | 8048 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 420 | 0.060 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2003 | 550 | 0.050 |
Why?
|
| Length of Stay | 1 | 2016 | 6417 | 0.050 |
Why?
|
| Cephalothin | 1 | 2001 | 28 | 0.050 |
Why?
|
| Penicillin G | 1 | 2001 | 40 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2004 | 554 | 0.050 |
Why?
|
| Ampicillin | 1 | 2001 | 136 | 0.050 |
Why?
|
| Gentamicins | 1 | 2001 | 244 | 0.040 |
Why?
|
| Cephalosporins | 1 | 2001 | 198 | 0.040 |
Why?
|
| Total Quality Management | 1 | 2001 | 262 | 0.040 |
Why?
|
| Penicillins | 1 | 2001 | 403 | 0.040 |
Why?
|
| Female | 9 | 2023 | 392552 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 637 | 0.030 |
Why?
|
| Estrogens | 1 | 2002 | 1522 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1999 | 702 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 1233 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1530 | 0.020 |
Why?
|
| Humans | 10 | 2023 | 761222 | 0.020 |
Why?
|
| Uterine Contraction | 1 | 1991 | 91 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2517 | 0.020 |
Why?
|
| Infant Mortality | 1 | 1995 | 752 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1995 | 707 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 1991 | 272 | 0.020 |
Why?
|
| Adult | 5 | 2016 | 221120 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1995 | 2106 | 0.020 |
Why?
|
| Gravidity | 1 | 2004 | 50 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 1780 | 0.010 |
Why?
|
| Preconception Care | 1 | 2004 | 141 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7407 | 0.010 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2001 | 41 | 0.010 |
Why?
|
| Endometritis | 1 | 2001 | 49 | 0.010 |
Why?
|
| Hospitals, Voluntary | 1 | 2001 | 39 | 0.010 |
Why?
|
| Maternal Age | 1 | 2004 | 809 | 0.010 |
Why?
|
| Colombia | 1 | 2001 | 282 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 869 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2004 | 1067 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 20982 | 0.010 |
Why?
|
| Wales | 1 | 1995 | 87 | 0.010 |
Why?
|
| France | 1 | 1995 | 492 | 0.010 |
Why?
|
| England | 1 | 1995 | 526 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2001 | 1037 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2923 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2004 | 54437 | 0.010 |
Why?
|
| Cardiotocography | 1 | 1991 | 24 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2001 | 1789 | 0.010 |
Why?
|
| Japan | 1 | 1995 | 1378 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2004 | 26200 | 0.010 |
Why?
|
| Poverty | 1 | 2001 | 2691 | 0.010 |
Why?
|
| Birth Weight | 1 | 1995 | 2104 | 0.000 |
Why?
|
| Boston | 1 | 1999 | 9327 | 0.000 |
Why?
|
| Data Interpretation, Statistical | 1 | 1995 | 2691 | 0.000 |
Why?
|
| United States | 3 | 2002 | 72341 | 0.000 |
Why?
|
| Risk Factors | 2 | 2003 | 74241 | 0.000 |
Why?
|
| United States Food and Drug Administration | 1 | 1991 | 1662 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 88300 | 0.000 |
Why?
|
| Child | 1 | 2003 | 80154 | 0.000 |
Why?
|
| Male | 1 | 2004 | 360703 | 0.000 |
Why?
|